Positions

Overview

  • Dr. Brown is an Associate Professor of Medicine in the UAB Division of Cardiovascular Disease. He attended medical school at the Louisiana State University (LSU) Health Sciences Center in New Orleans, LA and completed his Internal Medicine training at the LSU Internal Medicine Residency in Baton Rouge, LA where he served as Chief Medical Resident. After finishing his training at LSU, he came to UAB to pursue his Cardiovascular Disease training. While at UAB, he completed a MSPH in health services and outcomes research and also served as Chief Fellow during his final year of fellowship. After fellowship, Dr. Brown joined the UAB faculty in the Preventive Cardiology Section of the UAB Division of Cardiovascular Disease where he is an Associate Professor and also serves as the Director of Outpatient Services and Associate Program Director of the Cardiovascular Disease Fellowship Program. In addition to his clinical responsibilities, he is actively involved in research focusing on the epidemiology and secondary prevention of cardiovascular diseases including studying the utilization and benefits of cardiac rehabilitation. He also currently serves on the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) Board of Directors as well as national committees for the American Heart Association and American College of Cardiology. In recent years, he has been heavily involved in the AACVPR cardiac and pulmonary rehabilitation registries.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2018 Causes and temporal patterns of 30-day readmission among older adults hospitalized with heart failure with preserved or reduced ejection fraction 2018
    2018 N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study 2018
    2017 Design and interpretation of non-inferiority studies: A clinician’s perspective 2017
    2017 Statin Discontinuation, Reinitiation, and Persistence Patterns among Medicare Beneficiaries after Myocardial Infarction: A Cohort Study 2017
    2017 Medical therapy following hospitalization for heart failure with reduced ejection fraction and association with discharge to long-term care: A cross-sectional analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) population 2017
    2017 Metabolic syndrome cluster does not provide incremental prognostic information in patients with stable cardiovascular disease: A post hoc analysis of the AIM-HIGH trial 2017
    2017 Adherence to high-intensity statins following a myocardial infarction hospitalization among medicare beneficiaries 2017
    2017 Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014 2017
    2017 Insurance, self-reported medication adherence and LDL cholesterol: The REasons for Geographic And Racial Differences in Stroke study 2017
    2017 Comparison of expert adjudicated coronary heart disease and cardiovascular disease mortality with the National Death Index: Results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study 2017
    2017 Race-sex differences in statin use and low-density lipoprotein cholesterol control among people with diabetes mellitus in the reasons for geographic and racial differences in stroke study 2017
    2017 Significant Discrepancy Between Estimated and Actual Longevity in St. Jude Medical Implantable Cardioverter-Defibrillators 2017
    2017 Albuminuria, kidney function, and sudden cardiac death: Findings from The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study 2017
    2017 Proprotein convertase subtilisin/kexin 9 (PCSK9) inhibition in patients with or at high risk of coronary heart disease 2017
    2017 Quality of anticoagulation control and hemorrhage risk among African American and European American warfarin users 2017
    2016 Diabetes, diabetes severity, and coronary heart disease risk equivalence: REasons for Geographic and Racial Differences in Stroke (REGARDS) 2016
    2016 Effect of Left Ventricular Systolic Dysfunction on Response to Warfarin 2016
    2016 Comparison of length of stay, 30-day mortality, and 30-day readmission rates in medicare patients with heart failure and with reduced versus preserved ejection fraction 2016
    2016 Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage among Warfarin Users 2016
    2016 Response to Letter Regarding Article, "southern Dietary Pattern is Associated with Hazard of Acute Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study" 2016
    2015 Power and sample size in clinical studies 2015
    2015 Race influences warfarin dose changes associated with genetic factors 2015
    2015 Characteristics and prognosis of acute myocardial infarction by discharge diagnosis: The Reasons for Geographic and Racial Differences in Stroke study 2015
    2015 Race-sex differences in the management of hyperlipidemia: The reasons for geographic and racial differences in stroke study 2015
    2015 Statin use following hospitalization among Medicare beneficiaries with a secondary discharge diagnosis of acute myocardial infarction 2015
    2015 Southern dietary pattern is associated with hazard of acute coronary heart disease in the reasons for geographic and Racial Differences in Stroke (REGARDS) study 2015
    2015 Trends in mortality and recurrent coronary heart disease events after an acute myocardial infarction among Medicare beneficiaries, 2001-2009 2015
    2015 Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease 2015
    2014 Effect of sustaining lifestyle modifications (nonsmoking, weight reduction, physical activity, and Mediterranean diet) after healing of myocardial infarction, percutaneous intervention, or coronary bypass (from the reasons for geographic and racial differences in stroke study) 2014
    2014 Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: Results from the REGARDS Study (REasons for Geographic and Racial Differences in Stroke) 2014
    2014 Claims-based algorithms for identifying Medicare beneficiaries at high estimated risk for coronary heart disease events: A cross-sectional study 2014
    2014 Aspirin as Primary Prevention of Acute Coronary Heart Disease Events. 2014
    2014 Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetes 2014
    2014 Influence of regular physical activity on warfarin dose and risk of hemorrhagic complications 2014
    2014 Metabolic syndrome, C-reactive protein, and mortality in U.S. blacks and whites: The reasons for geographic and racial differences in Stroke (REGARDS) study 2014
    2013 Awareness, treatment, and control of LDL cholesterol are lower among U.S. adults with undiagnosed diabetes versus diagnosed diabetes 2013
    2013 Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 Through 2009-2010 2013
    2013 Cardioprotective medication use and risk factor control among US adults with unrecognized myocardial infarction: The REasons for geographic and racial differences in stroke (REGARDS) study 2013
    2013 Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: An observational study 2013
    2012 Awareness and management of chronic disease, insurance status, and health professional shortage areas in the REasons for Geographic and Racial Differences in Stroke (REGARDS): A cross-sectional study 2012
    2012 Association of race and sex with risk of incident acute coronary heart disease events 2012
    2012 Nonalcoholic Fatty Liver Disease and Cardiovascular Disease Risk 2012
    2012 Awareness, treatment and control of hypertension, diabetes and hyperlipidemia and area-level mortality regions in the reasons for geographic and racial differences in stroke (REGARDS) study 2012
    2012 Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease 2012
    2012 Use of secondary prevention medications among adults with reduced kidney function 2012
    2012 The role of cardiac rehabilitation in heart failure patients 2012
    2011 Association of the metabolic syndrome with atrial fibrillation among United States adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study) 2011
    2011 Heart disease and stroke statistics-2011 update: A report from the American Heart Association 2011
    2011 Cardiac rehabilitation outcomes: impact of comorbidities and age. 2011
    2011 Clinical Research in Cardiac Rehabilitation and Secondary Prevention 2011
    2011 Health professional shortage areas, insurance status, and cardiovascular disease prevention in the reasons for geographic and racial differences in stroke (REGARDS) study 2011
    2010 Exercise as a treatment for the risk of cardiovascular disease 2010
    2010 Variations in prevalent cardiovascular disease and future risk by metabolic syndrome classification in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study 2010
    2010 Heart disease and stroke statistics--2010 update: a report from the American Heart Association. 2010
    2010 Executive summary: Heart disease and stroke statistics-2010 update: A report from the american heart association 2010
    2009 Biomarkers of atherosclerosis: Clinical applications 2009
    2009 Predictors of Cardiac Rehabilitation Referral in Coronary Artery Disease Patients. Findings From the American Heart Association's Get With The Guidelines Program 2009
    2009 Drugs are not enough: The metabolic syndrome - A call for intensive therapeutic lifestyle change 2009
    2009 Assessing patient recall of discharge instructions for acute myocardial infarction. 2009
    2008 Biomarkers of atherosclerosis: Clinical applications 2008
    2008 Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria? 2008
    2007 Management of stable patients with coronary heart disease: Clinical implications of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial 2007
    2006 B-type natriuretic peptide level in a patient with constrictive pericarditis 2006
    2006 Quantification of tricuspid regurgitation by live three-dimensional transthoracic echocardiographic measurements of vena contracta area 2006
    2005 Acute Hepatitis E Infection in a Visitor to Louisiana 2005

    Principal Investigator On

  • Private Grant  awarded by OMTHERA PHARMACEUTICALS 2014 - 2021
  • Investigator On

  • Patient Oriented Research in Personalized Antithrombotic Therapy  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2016 - 2021
  • REasons for Geographic and Racial Differences in Stroke-Myocardial Infarction-3  awarded by Cornell University 2017 - 2021
  • Implementation of a Shared Decision Making Intervention in Practice: The Chest Pain Choice Pathway  awarded by PATIENT CENTERED OUTCOMES RESEARCH INSTITUTE 2018 - 2020
  • Private Grant  awarded by AMGEN, INC. 2019 - 2020
  • Private Grant  awarded by AMGEN, INC. 2019 - 2020
  • Private Grant  awarded by AMGEN, INC. 2018 - 2019
  • Genetic and Clinical Predictors of Response to Warfarin and Novel Anticoagulants  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2014 - 2019
  • Private Grant  awarded by AMGEN, INC. 2017 - 2018
  • Private Grant  awarded by HAMILTON HEALTH SCIENCES CORPORATION 2013 - 2018
  • Private Grant  awarded by Bayer HealthCare 2013 - 2018
  • Private Grant  awarded by AMGEN, INC. 2016 - 2018
  • Private Grant  awarded by ASTRAZENECA PHARMACEUTICALS LP 2015 - 2018
  • Reasons for Geographic AND Racial Differences in Stroke-Myocardial Infarction-2  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2015 - 2017
  • Private Grant  awarded by AMGEN, INC. 2015 - 2016
  • Private Grant  awarded by AMGEN, INC. 2015 - 2016
  • Private Grant  awarded by AUM CARDIOVASCULAR 2013 - 2016
  • Private Grant  awarded by AMGEN, INC. 2014 - 2015
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2014 - 2015
  • REasons for Geographic And Racial Differences in Stroke-Myocardial Infarction-2  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2011 - 2015
  • Private Grant  awarded by Pfizer Pharmaceuticals 2014 - 2015
  • Private Grant  awarded by AMGEN, INC. 2014 - 2015
  • Private Grant  awarded by REGENERON PHARMACEUTICALS, INC. 2014
  • Deep South Resource Center for Minority Aging Research  awarded by National Institute on Aging/NIH/DHHS 2012 - 2014
  • Deep South Resource Center for Minority Aging Research - Investigator Development Core  awarded by National Institute on Aging/NIH/DHHS 2012 - 2014
  • Private Grant  awarded by AMGEN, INC. 2013 - 2014
  • Private Grant  awarded by GlaxoSmithKline 2008 - 2013
  • Private Grant  awarded by AMGEN, INC. 2012 - 2013
  • Education And Training

  • Earl K. Long Medical Center, Internship 2002
  • Earl K. Long Medical Center, Residency 2005
  • UAB Hospital, Postdoctoral Fellowship 2009
  • Full Name

  • Todd Brown